期刊文献+

逆转录病毒介导HyTK 基因治疗膀胱癌的实验研究 被引量:5

Retroviral mediated transfer of a hygromycin phosphotransferase thymidine kinase fusion gene into human bladder carcinoma cell
原文传递
导出
摘要 目的 了解逆转录病毒介导的潮霉素磷酸转移酶和 H S V T K 的融合基因( Hy T K) 的基因转移联合更昔洛韦( G C V) 对膀胱癌细胞的杀伤作用。 方法 构建重组质粒p L( Hy T K) S N,应用非脂质体基因转导系统 Fu G E N E T M6 及“乒乓效应”(pingpong mechanism) ,获得高滴度重组病毒并转染膀胱癌细胞株 E J,增强型绿色荧光蛋白( E G F P) 报告基因检测转移效率,检测 Hy T K 基因的表达及 G C V 对转基因细胞 E J/ Hy T K 的杀伤作用。 结果 本实验逆转录病毒的转染效率为35 % 左右, Southern Blot、 Dot Blot 及免疫组化检测证实 Hy T K 在转基因细胞的表达, M T T法测定示 G C V 对 E J/ Hy T K 细胞有明显的杀伤作用。其 I C50 值为107μg/ml,而对其亲代 E J细胞无明显杀伤作用( P< 005) 。按不同比例混合 E J/ Hy T K 细胞和亲代 E J细胞,发现 G C V 不仅能杀伤转入 T K 基因的细胞,而且对其周围未转基因的膀胱癌细胞存在旁观者效应,此效应并无细胞株间的特异性。 结论 逆转录病毒介导的 Hy T K Objective To evaluate the therapeutic efficacy of retroviral mediated hygromycin phosphotransferase thymidine kinase fusion gene (HyTK)/GCV on human bladder carcinoma cell. Methods A retroviral expression vector pL(HyTK)SN was constructed.By using FuGENE TM 6 mediated transfection and “ping pong effect”technique, high titer of retroviral supernatant was obtained and HyTK gene was transferred into EJ cells. A retroviral vector encoding, enhanced green fluorescent protein,EGFP was used to rapidly detect the transduction efficiency. Antitumor effects were observed after GCV treatment. Results In vitro experiments demonstrated the EJ cells transferred by HyTK gene were killed in the GCV treatment. Nontransduced parental cells were not sensitive to GCV, but they were dead by the bystander killing of neighboring cells when mixed with EJ/HyTK cells at various ratios. In addition, this not only affect wild type EJ cells but also cells from different bladder carcinoma cell lines. Conclusions Retroviral mediated HyTK/GCV systems were a promising suicide gene therapy for bladder carcinoma. EGFP may act as a convenient and rapid reporter to monitor retroviral mediated gene transfer and expression in bladder carcinoma cells.
出处 《中华外科杂志》 CAS CSCD 北大核心 1999年第8期453-455,I033,共4页 Chinese Journal of Surgery
关键词 膀胱肿瘤 基因治疗 HYTK基因 逆转录病毒 Bladder neoplasms Gene therapy
  • 相关文献

参考文献9

  • 1叶传忠,陈仕平,裴雪涛,冯凯,李梁,杨光.脂质体介导的HSV-TK基因治疗人膀胱癌[J].中华实验外科杂志,1999,16(1):24-25. 被引量:9
  • 2高文廉 裴雪涛 等.逆转录病毒载体介导的人多药耐药基因(mdr-1)导入小鼠造血细胞的实验研究[J].中国应用生理学杂志,1998,14:113-116.
  • 3叶传忠 陈仕平 等.MIB-1单克隆抗体评价膀胱移行细胞癌增殖活性的研究[J].中华外科杂志,1999,37:126-126.
  • 4F.奥斯伯 颜子颖(译).精编分子生物学实验指南,第1版[M].北京:科学出版社,1998.59-60,63-65,141-146.
  • 5叶传忠,中华实验外科杂志,1999年,16卷,24页
  • 6叶传忠,中华外科杂志,1999年,37卷,126页
  • 7高文谦,中国应用生理学杂志,1998年,14卷,113页
  • 8颜子颖(译),精编分子生物学实验指南,1998年,59页
  • 9Sheng Y,Nucleic Acids Res,1995年,23卷,1990页

二级参考文献2

  • 1Kwong Y L,Current Protocols in Human Genetics Copyrinhto 1997,1997年,1355页
  • 2Sheng Y,Nucleic Acids Res,1995年,23卷,1990页

共引文献9

同被引文献27

  • 1F.奥斯伯 颜子颖(译).精编分子生物学实验指南[M].北京:科学出版社,1998.141.
  • 2[1]吴在德.外科学[M].北京;人民卫生出版社,2000,766.
  • 3[2]Pow-Sang J M, Seigne J D. Contemporary management of superficial bladder cancer[J]. Cancer Control ,2000,7 (4) :335-339.
  • 4[3]Ardelt P,Bohle A. Molecular aspects of bladder cancer I V: gene therapy of bladder cancer[J]. Eur Urol,2002,41 (4): 372-381.
  • 5[4]Irie A, Uchida T, Ishida H,et al. p53 Mutation in bladder cancer patients in Japan and inhibition of growth by in vitro edanovirusmediated wild-type p53 transduction in bladder cancer cells[J].Mol Urol,2001,5(2) :53 -58.
  • 6[5]Weda Y,Gotoh A, Shirakawa T,et al. Gene therapy for bladder cancer using edenoviral vector[J]. Mol Urol,2001,5 (2) :47-52.
  • 7[6]Pagliaro L C. Gene therapy for bladder cancer[J]. World J Urol,2000,18(2) :148 - 151.
  • 8[7]Xu H J,Zhou Y,Seigne J,et al. Enhanced tumor suppressor gene therapy via replication-deficient adenovirus vectors expressing an N-terminal truncated retinoblastoma protein [J]. Cancer Res,1996 ,56 ( 10 ) :2245 - 2249
  • 9[8]Grim J, D, Amico A, Frizelle S, et al. Adenovims - mediated delivery of p16 to p16-deficient human bladder cancer cells confers chemoresistance to cisplatin and paclitaxel[J]. Clin Cancer Res,1997,3(12 Pt 1):2415-2423.
  • 10[9]Cairns P, Evron E, Okami K, et al. Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers[J].Oncogene,1998,16(24) :3215 -3218.

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部